TY - JOUR AU - Jemal, A. AU - Bray, F. AU - Center, M. M. AU - Ferlay, J. AU - Ward, E. AU - Forman, D. PY - 2011 DA - 2011// TI - Global cancer statistics JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20107 DO - 10.3322/caac.20107 ID - Jemal2011 ER - TY - STD TI - National Cancer Center. National Cancer Information Center. 2015. http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040201000000. Accessed 30 Mar 2015. UR - http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040201000000 ID - ref2 ER - TY - JOUR AU - Louvet, C. AU - Labianca, R. AU - Hammel, P. AU - Lledo, G. AU - Zampino, M. G. AU - André, T. PY - 2005 DA - 2005// TI - Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.06.023 DO - 10.1200/JCO.2005.06.023 ID - Louvet2005 ER - TY - JOUR AU - Siegel, R. AU - Ma, J. AU - Zou, Z. AU - Jemal, A. PY - 2014 DA - 2014// TI - Cancer statistics, 2014 JO - CA Cancer J Clin VL - 64 UR - https://doi.org/10.3322/caac.21208 DO - 10.3322/caac.21208 ID - Siegel2014 ER - TY - JOUR AU - Manuela Quaresma, L. AU - Coleman, M. P. AU - Rachet, B. PY - 2015 DA - 2015// TI - 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study JO - Lancet VL - 385 ID - Manuela Quaresma2015 ER - TY - JOUR AU - Burris, H. A. AU - Moore, M. J. AU - Andersen, J. AU - Green, M. R. AU - Rothenberg, M. L. AU - Modiano, M. R. PY - 1997 DA - 1997// TI - Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial JO - J Clin Oncol VL - 15 ID - Burris1997 ER - TY - JOUR AU - Hochster, H. S. AU - Haller, D. G. AU - Ad, G. AU - Berlin, J. D. AU - Philip, P. A. AU - Moore, M. J. PY - 2006 DA - 2006// TI - Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer JO - Cancer VL - 107 UR - https://doi.org/10.1002/cncr.22036 DO - 10.1002/cncr.22036 ID - Hochster2006 ER - TY - JOUR AU - Bria, E. AU - Milella, M. AU - Gelibter, A. AU - Cuppone, F. AU - Pino, M. S. AU - Ruggeri, E. M. PY - 2007 DA - 2007// TI - Gemcitabine-based combinations for inoperable pancreatic cancer: have We made real progress? a meta-analysis of 20 phase 3 trials JO - Cancer VL - 110 UR - https://doi.org/10.1002/cncr.22809 DO - 10.1002/cncr.22809 ID - Bria2007 ER - TY - JOUR AU - Sun, C. AU - Ansari, D. AU - Andersson, R. AU - Wu, D. -. Q. PY - 2012 DA - 2012// TI - Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? JO - World J Gastroenterol VL - 18 UR - https://doi.org/10.3748/wjg.v18.i35.4944 DO - 10.3748/wjg.v18.i35.4944 ID - Sun2012 ER - TY - JOUR AU - Kindler, H. L. AU - Niedzwiecki, D. AU - Hollis, D. AU - Sutherland, S. AU - Schrag, D. AU - Hurwitz, H. PY - 2010 DA - 2010// TI - Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the cancer and leukemia group B (CALGB 80303) JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.28.1386 DO - 10.1200/JCO.2010.28.1386 ID - Kindler2010 ER - TY - JOUR AU - Philip, P. A. AU - Benedetti, J. AU - Corless, C. L. AU - Wong, R. AU - O’Reilly, E. M. AU - Flynn, P. J. PY - 2010 DA - 2010// TI - Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: southwest oncology group-directed intergroup trial S0205 JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.7550 DO - 10.1200/JCO.2009.25.7550 ID - Philip2010 ER - TY - JOUR AU - Moore, M. J. AU - Goldstein, D. AU - Hamm, J. AU - Figer, A. AU - Hecht, J. R. AU - Gallinger, S. PY - 2007 DA - 2007// TI - Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the national cancer institute of Canada clinical trials group JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.07.9525 DO - 10.1200/JCO.2006.07.9525 ID - Moore2007 ER - TY - JOUR AU - Yang, Z. -. Y. AU - Yuan, J. -. Q. AU - Di, M. -. Y. AU - Zheng, D. -. Y. AU - Chen, J. -. Z. AU - Ding, H. PY - 2013 DA - 2013// TI - Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0057528 DO - 10.1371/journal.pone.0057528 ID - Yang2013 ER - TY - JOUR AU - Seong, J. AU - Choi, N. AU - Shin, J. AU - Chang, Y. AU - Kim, Y. AU - Lee, J. PY - 2015 DA - 2015// TI - Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, All in combination with metformin, for type 2 diabetes: a population-based cohort study JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0124287 DO - 10.1371/journal.pone.0124287 ID - Seong2015 ER - TY - JOUR AU - Song, I. AU - Choi, S. AU - Shin, J. PY - 2016 DA - 2016// TI - Trends in prescription of pregnancy-contraindicated drugs in Korea, 2007-2011 JO - Regul Toxicol Pharmacol VL - 75 UR - https://doi.org/10.1016/j.yrtph.2015.12.011 DO - 10.1016/j.yrtph.2015.12.011 ID - Song2016 ER - TY - JOUR AU - Lee, C. AU - Hyun, M. AU - Jang, E. AU - Lee, N. AU - Kim, K. AU - Yim, J. PY - 2013 DA - 2013// TI - Inhaled corticosteroid use and risks of lung cancer and laryngeal cancer JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2012.12.002 DO - 10.1016/j.rmed.2012.12.002 ID - Lee2013 ER - TY - JOUR AU - Lee, Y. AU - Kim, K. AU - Ha, Y. AU - Koo, K. PY - 2015 DA - 2015// TI - Utilization of hyaluronate and incidence of septic knee arthritis in adults: results from the Korean national claim registry JO - Clin Orthop Surg VL - 7 UR - https://doi.org/10.4055/cios.2015.7.3.318 DO - 10.4055/cios.2015.7.3.318 ID - Lee2015 ER - TY - JOUR AU - Shin, J. AU - Choi, N. AU - Lee, J. AU - Seong, J. AU - Park, M. AU - Lee, S. PY - 2015 DA - 2015// TI - Risk of ischemic stroke associated with the use of antipsychotic drugs in elderly patients: a retrospective cohort study in Korea JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0119931 DO - 10.1371/journal.pone.0119931 ID - Shin2015 ER - TY - JOUR AU - Quan, H. AU - Sundararajan, V. AU - Halfon, P. AU - Fong, A. AU - Burnand, B. AU - Luthi, J. -. C. PY - 2005 DA - 2005// TI - Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data JO - Med Care VL - 43 UR - https://doi.org/10.1097/01.mlr.0000182534.19832.83 DO - 10.1097/01.mlr.0000182534.19832.83 ID - Quan2005 ER - TY - BOOK PY - 2014 DA - 2014// TI - National health insurance statistical yearbook 2013 PB - National Health Insurance Service CY - Seoul ID - ref20 ER - TY - BOOK AU - Ahn, J. AU - Kim, Y. AU - Shin, S. AU - Park, J. PY - 2012 DA - 2012// TI - Value for a QALY in Asia PB - National Evidence-based Healthcare Collaborating Agency CY - Seoul ID - Ahn2012 ER - TY - JOUR AU - Hoff, D. D. V. AU - Ervin, T. AU - Arena, F. P. AU - Chiorean, E. G. AU - Infante, J. AU - Moore, M. PY - 2013 DA - 2013// TI - Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine JO - NEJM VL - 369 UR - https://doi.org/10.1056/NEJMoa1304369 DO - 10.1056/NEJMoa1304369 ID - Hoff2013 ER - TY - JOUR AU - Booth, C. M. AU - Tannock, I. F. PY - 2014 DA - 2014// TI - Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2013.725 DO - 10.1038/bjc.2013.725 ID - Booth2014 ER - TY - JOUR AU - Leonard, D. T. PY - 2010 DA - 2010// TI - Comparative effectiveness and real-world evidence JO - Am J Manag Care VL - 16 ID - Leonard2010 ER - TY - JOUR AU - Conroy, T. AU - Desseigne, F. AU - Ychou, M. AU - Bouché, O. AU - Guimbaud, R. AU - Bécouarn, Y. PY - 2011 DA - 2011// TI - FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer JO - NEJM VL - 364 UR - https://doi.org/10.1056/NEJMoa1011923 DO - 10.1056/NEJMoa1011923 ID - Conroy2011 ER - TY - JOUR AU - Tam, V. C. AU - Ko, Y. J. AU - Mittmann, N. AU - Cheung, M. C. AU - Kumar, K. AU - Hassan, S. PY - 2013 DA - 2013// TI - Cost-effectiveness of systemic therapies for metastatic pancreatic cancer JO - Curr Oncol VL - 20 UR - https://doi.org/10.3747/co.20.1223 DO - 10.3747/co.20.1223 ID - Tam2013 ER - TY - JOUR AU - Wang-Gillam, A. AU - Li, C. P. AU - Bodoky, G. AU - Dean, A. AU - Shan, Y. S. AU - Jameson, G. PY - 2016 DA - 2016// TI - Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)00986-1 DO - 10.1016/S0140-6736(15)00986-1 ID - Wang-Gillam2016 ER -